Product Overview
Lapatinib ditosylate | T0078L | TargetMol Chemicals
CAS: 388082-78-8
Smiles: O.Cc1ccc(cc1)S(O)(=O)=O.Cc1ccc(cc1)S(O)(=O)=O.CS(=O)(=O)CCNCc1ccc(o1)-c1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1
Formula: C43H44ClFN4O11S3
Pathway: Angiogenesis|||Apoptosis|||Autophagy|||Cell Cycle/Checkpoint|||JAK/STAT signaling|||Tyrosine Kinase/Adaptors
Target: EGFR|||Ferroptosis|||Autophagy
Receptor: N/A
Bioactivity: Lapatinib is a tyrosine kinase receptor inhibitor used in the therapy of advanced breast cancer and other solid tumors. Lapatinib therapy is associated with transient elevations in serum aminotransferase levels and rare instances of clinically apparent acute liver injury.
Molecular Weight: 943, 47
